Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06024200
Status:
RECRUITING
Last Update Posted:
2023-09-11
First Post:
2023-08-16
Brief Title:
Transcutaneous Electrical Acupoint Stimulation for Opioid Consumption After Gastrointestinal Laparoscopic Surgery
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
Effect of Whole-process Transcutaneous Electrical Acupoint Stimulation on Opioid Consumption After Gastrointestinal Laparoscopic Surgery a Prospective Randomised Blinded Placebo-controlled Study
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the effect of whole-process transcutaneous electrical acupoint stimulation on opioid consumption after gastrointestinal laparoscopic surgery All subjects received conventional multimodal analgesia On this basis the experimental group received whole-process transcutaneous electrical acupoint stimulation while the control group received corresponding false stimulation
Detailed Description:
Conventional multimodal analgesia protocols as follows
1 Before the end of the operation the surgical incision was infiltrated with 05 ropivacaine 10 mL locally
2 Patients were transferred to the PACU and provided with patient-controlled intravenous analgesia with sufentanil for postoperative analgesia The analgesia devices were set to a concentration of 1ugmL with a lockout interval of 15 minutes and a 3 mL boluswithout an infusion dose The pump was withdrawn 72h after surgery
3 Flurbiprofen 50mg per dose intravenously twice a day for postoperative three days
1 Before the end of the operation the surgical incision was infiltrated with 05 ropivacaine 10 mL locally
2 Patients were transferred to the PACU and provided with patient-controlled intravenous analgesia with sufentanil for postoperative analgesia The analgesia devices were set to a concentration of 1ugmL with a lockout interval of 15 minutes and a 3 mL boluswithout an infusion dose The pump was withdrawn 72h after surgery
3 Flurbiprofen 50mg per dose intravenously twice a day for postoperative three days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None